Overview

A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal Encephalitis

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability and effectiveness of rituximab in the treatment of chronic focal encephalitis.
Phase:
Phase 1
Details
Lead Sponsor:
California Pacific Medical Center Research Institute
Collaborator:
Genentech, Inc.
Treatments:
Rituximab